Reducing GLT‐1 expression aggravates disease severity in rodent models of amyotrophic lateral sclerosis (Pardo et al. 2006) and Alzheimer's disease (Mookherjee et al. 2011). Here, SLC1A2 is linked to Alzheimer disease.